Macrobid and Tamiflu drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Macrobid (nitrofurantoin; nitrofurantoin, macrocrystalline) and Tamiflu (oseltamivir phosphate). Common drug interactions include fall among females and scar among males.

The phase IV clinical study analyzes what interactions people have when they take Macrobid and Tamiflu. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Macrobid?

Macrobid has active ingredients of nitrofurantoin; nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 9,215 Macrobid users. Check the latest studies of Macrobid.

What is Tamiflu?

Tamiflu has active ingredients of oseltamivir phosphate. It is often used in the flu. eHealthMe is studying from 22,209 Tamiflu users. Check the latest studies of Tamiflu.



On Jul, 06, 2026

53 people who take Macrobid and Tamiflu together, and have interactions are studied.

Macrobid and Tamiflu drug interactions.

What are the common drug interactions of Macrobid and Tamiflu, by gender? *:

female:

  1. Fall
  2. Hypertension (high blood pressure)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Aortic arteriosclerosis (hardening of the aortic arteries)
  5. Cough
  6. Discomfort
  7. Dry mouth
  8. Dysphonia (speech disorder attributable to a disorder of phonation)
  9. Dyspnoea (difficult or laboured respiration)
  10. Feeling jittery

male:

  1. Scar
  2. Acute sinusitis
  3. Bone loss
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Candidiasis (candidiasis or thrush is a fungal infection)
  6. Carcinoma in situ of skin
  7. Cellulitis (infection under the skin)
  8. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  9. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  10. Constipation

What are the common drug interactions of Macrobid and Tamiflu, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Scar
  2. Acute sinusitis
  3. Anaemia (lack of blood)
  4. Angiopathy (generic term for a disease of the blood vessels)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Aortic arteriosclerosis (hardening of the aortic arteries)
  8. Arthropathy
  9. Back pain
  10. Bone disorder

10-19:

  1. Gallbladder operation
  2. Hospitalisation

20-29:

  1. Abdominal pain upper
  2. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  3. Chest pain
  4. Cholecystitis chronic (long lasting infection of gallbladder)
  5. Diarrhoea
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Helicobacter gastritis (inflammation of the inner lining of the stomach caused by helicobacter pylori (h. pylori) a bacterium)
  8. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  9. Nausea (feeling of having an urge to vomit)
  10. Peptic ulcer

30-39:

  1. Abnormal behaviour
  2. Agitation (state of anxiety or nervous excitement)
  3. Coma (state of unconsciousness lasting more than six hours)
  4. Ear pain
  5. Fatigue (feeling of tiredness)
  6. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  7. Hallucination (an experience involving the perception of something not present)
  8. Hepatic failure (liver failure)
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Insomnia (sleeplessness)

40-49:

  1. Drug ineffective
  2. H1n1 influenza (flu (influenza), which is caused by virus influenza a (h1n1))
  3. Injection site erythema (redness at injection site)
  4. Weight decreased
  5. Abdominal discomfort
  6. Anal fistula

50-59:

  1. Alcohol abuse
  2. Loss of consciousness
  3. Self esteem decreased (self worth reduced)
  4. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  5. Suicidal ideation
  6. Weight increased

60+:

  1. Pain
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Discomfort
  4. Dry mouth
  5. Dysphonia (speech disorder attributable to a disorder of phonation)
  6. Dyspnoea (difficult or laboured respiration)
  7. Emotional distress
  8. Feeling jittery
  9. Fractured sacrum
  10. Gingival bleeding (bleeding gums)

What are the existing conditions these people have? *

  1. Osteoporosis (bones weak and more likely to break): 24 people, 45.28%
  2. Pain: 6 people, 11.32%
  3. Immunodeficiency Common Variable: 6 people, 11.32%
  4. Depression: 4 people, 7.55%
  5. Stress And Anxiety: 3 people, 5.66%
  6. High Blood Cholesterol: 3 people, 5.66%
  7. Cardiac Disorder: 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Macrobid and Tamiflu?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Macrobid and Tamiflu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Macrobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tamiflu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Macrobid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tamiflu and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nitrofurantoin; nitrofurantoin, macrocrystalline and oseltamivir phosphate (the active ingredients of Macrobid and Tamiflu, respectively), and Macrobid and Tamiflu (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: